(Q45227228)

English

Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women

scientific article published on 15 January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

1 reference

based on heuristic

inferred from title

medroxyprogesterone acetate

1 reference

based on heuristic

inferred from title

author name string

Robert Lindsay

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

J Christopher Gallagher

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Michael Kleerekoper

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

James H Pickar

4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

language of work or name

0 references

publication date

15 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Osteoporosis International

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

372-379

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

https://scigraph.springernature.com/pub.10.1007/s00198-004-1773-4

0 references

Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/15654581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of Alora estradiol matrix transdermal delivery system in improving lumbar bone mineral density in healthy, postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/15654581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI

1 reference

https://pubmed.ncbi.nlm.nih.gov/15654581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/15654581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate

1 reference

https://pubmed.ncbi.nlm.nih.gov/15654581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate

1 reference

https://pubmed.ncbi.nlm.nih.gov/15654581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and local tolerance of a low-dose, 7-day matrix estradiol transdermal system in the treatment of menopausal vasomotor symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/15654581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix delivery transdermal 17beta-estradiol for the prevention of bone loss in postmenopausal women. The International Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15654581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/15654581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15654581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/15654581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15654581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15654581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15654581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15654581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring individual response to hormone replacement therapy with bone markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/15654581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding

1 reference

https://pubmed.ncbi.nlm.nih.gov/15654581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A dose-ranging trial of a matrix transdermal 17beta-estradiol for the prevention of bone loss in early postmenopausal women. International Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15654581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How many women lose bone mineral density while taking hormone replacement therapy? Results from the Postmenopausal Estrogen/Progestin Interventions Trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15654581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An estradiol matrix transdermal system for the prevention of postmenopausal bone loss

1 reference

https://pubmed.ncbi.nlm.nih.gov/15654581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00198-004-1773-4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45227228&oldid=2082974603"